Position in SANA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,712,767
+$449,567 QoQ
Shares Held
777,298
-1.1% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. SANA ranks #139 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,712,767 | 777,298 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,263,200 | 785,834 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,318,899 | 815,455 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,580,824 | 2,135,444 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,075,931 | 760,415 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,352,673 | 805,164 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,314,813 | 806,635 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,815,436 | 917,173 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $5,195,537 | 951,564 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $11,054,870 | 1,105,487 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $4,857,785 | 1,190,634 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $4,556,273 | 1,177,332 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,377,275 | 1,237,798 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,986,329 | 2,442,303 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $9,385,207 | 2,376,002 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,278,272 | 2,379,712 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,044,866 | 2,495,314 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $20,532,532 | 2,485,779 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $31,209,319 | 2,016,106 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $36,604,502 | 1,625,422 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $24,679,176 | 1,255,299 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $51,042,150 | 1,525,012 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||